[1]苏晓鹏,晏军,张潞潞,等.从阳虚体质探讨原发性肝癌的防治[J].西部中医药,2023,36(05):43-45.[doi:10.12174/j.issn.2096-9600.2023.05.09]
　SU Xiaopeng,YAN Jun,ZHANG Lulu,et al.Discussion on the Prevention and Treatment of Primary Liver Cancer from Yang Deficiency Constitution[J].Western Journal of Traditional Chinese Medicine,2023,36(05):43-45.[doi:10.12174/j.issn.2096-9600.2023.05.09]
点击复制

从阳虚体质探讨原发性肝癌的防治
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年05期
页码:
43-45
栏目:
出版日期:
2023-05-15

文章信息/Info

Title:
Discussion on the Prevention and Treatment of Primary Liver Cancer from Yang Deficiency Constitution
作者:
苏晓鹏1,2, 晏军1, 张潞潞3, 李玲孺' target="_blank" rel="external"> 李玲孺2, 党志博1, 李玲1, 周怡驰1, 胡世平4
1.北京中医药大学东直门医院,北京 100700
2.北京中医药大学,北京 100029
3.中国中医科学院中医基础理论研究所,北京 100700
4.北京中医药大学深圳医院肝病科，广东 深圳 518172
Author(s):
SU Xiaopeng1,2, YAN Jun1, ZHANG Lulu3, LI Lingru' target="_blank" rel="external"> LI Lingru2, DANG Zhibo1, LI Ling1, ZHOU Yichi1, HU Shiping4
1.Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, China
2.Beijing University of Chinese Medicine, Beijing 100029, China
3.Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
4.Hepatic Department, Shenzhen Hospital of Beijing University of Chinese Medicine, Shenzhen 518172, China
关键词:
原发性肝癌; 阳虚体质; 防治
Keywords:
primary liver cancer; deficiency constitution; prevention and treatment
分类号:
R223.1+4
DOI:
10.12174/j.issn.2096-9600.2023.05.09
文献标志码:
A
摘要:
结合肿瘤患者临床特点及相关文献，从阳虚体质着手，探讨阳虚体质与原发性肝癌的病因病机、治疗、复发、预防的关系，以期为临床诊治肝癌及防治提供新思路。
Abstract:
The correlation of Yang deficiency constitution with the cause, the pathogenesis, treatment, relapse and the prevention of primary liver cancer (PLC) is discussed based on clinical characteristics and the relevant literature of cancer patients, in the wish of providing new thinking for clinical diagnosis and treatment of liver cancer in clinic, and its prevention and treatment.

相似文献/References:

[1]钱丽,华海清△.华海清教授运用中药治疗索拉非尼所致腹泻的经验[J].西部中医药,2013,26(07):40.
　QIAN Li,HUA Haiqing.The Experience of Professor HUA Haiqing Using TCM to Diarrhea Induced by Sorafenib Tosylate[J].Western Journal of Traditional Chinese Medicine,2013,26(05):40.
[2]佘彬,陈雁,张瑞明.张瑞明教授治疗原发性肝癌临床经验初探[J].西部中医药,2018,31(01):30.
　SHE Bin,CHEN Yan,ZHANG Ruiming.Exploration into Professor Zhang Ruiming′s Clinical Experience of Treating Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(05):30.
[3]叶子怡,李海,宾炜,等.阳虚体质生物电阻抗身体成分特征分析[J].西部中医药,2017,30(12):38.
　YE Ziyi,LI Hai,BIN Wei,et al.Feature Analysis of Body Composition of Yang Deficiency Constitution by Bioelectrical Impedance[J].Western Journal of Traditional Chinese Medicine,2017,30(05):38.
[4]吴文卓,贺松其△.五运六气禀赋与原发性肝癌的相关性[J].西部中医药,2018,31(11):65.
　WU Wenzhuo,HE Songqi.The Correlation between Primary Liver Carcinoma and Natural Endowment of Five Movements and Six Climates[J].Western Journal of Traditional Chinese Medicine,2018,31(05):65.
[5]陈一贞,陈闯.原发性肝癌中医证型客观化研究进展[J].西部中医药,2023,36(02):146.[doi:10.12174/j.issn.2096-9600.2023.02.34]
　CHEN Yizhen,CHEN Chuang.Research Progress in TCM Syndromes Objectification of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(05):146.[doi:10.12174/j.issn.2096-9600.2023.02.34]
[6]孙阳,李松哲,孙悦,等.贞术消积汤治疗原发性肝癌组方浅析[J].西部中医药,2023,36(07):72.[doi:10.12174/j.issn.2096-9600.2023.07.17]
　SUN Yang,LI Songzhe,SUN Yue,et al.Brief Analysis of Zhenzhu Xiaoji Tang in the Treatment of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(05):72.[doi:10.12174/j.issn.2096-9600.2023.07.17]

备注/Memo

备注/Memo:
苏晓鹏（1993—），男，在读博士研究生。研究方向：中医治疗肝病与肿瘤的临床研究。国家自然科学基金面上项目（81973733）；广东省基础与应用基础研究基金面上项目（2019A1515011555）；深圳市科技计划（JCYJ20170306154458909）。
更新日期/Last Update: 2023-05-15